Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax

Appoints Leading Oncologist Professor Susana Banerjee of The Royal Marsden as Chief Investigator CAMBRIDGE, United Kingdom and MONTREAL, April 23, 2026 (GLOBE NEWSWIRE) — Epitopea, a transatlantic biotech developing off-the-shelf, durable, RNA-based cancer immunotherapies, today announced that it has received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Regional Ethics Committee (REC) for its clinical... The post Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer appeared first on Montreal Gazette.


61 h.
Technology
ID: 1399189469024413052


Similar News expand_more


Science
Education
Technology
Science
Technology
Technology
Technology
Science
Technology
Science
Science
Technology
Technology
Science
Technology
Technology
Science
Technology
Science
Technology
Science
Technology
Science
Technology
Technology
Sport
Science
Technology
Technology
Technology
Entertainment
Technology
Technology
Technology
Technology
Technology
Technology
Education
Technology
Technology
Economics
Technology
Technology
Technology
Technology
Science
Science
Education
Culture
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down